an analogue of L-DOPA is a tracer for presynaptic dopamine function in cerebral studies with PET. In order to use it safely and effectively in clinical study
quality control of 18FDOPA was studied. Determination of the enantiomeric purity of 18FDOPA by HPLC method using a chiral mobil phase and reversed-phase C18 column was described. All quality criteria of 18FDOPA met the requirements of the local pharmacopoeia. The relevant details involved in quality control of 18FDOPA might be useful in the future development of new radiopharmaceuticals for PET.